Baotou Dongbao Bio-Tech Co Ltd (300239) - Total Assets

Latest as of March 2026: CN¥2.57 Billion CNY ≈ $376.65 Million USD

Based on the latest financial reports, Baotou Dongbao Bio-Tech Co Ltd (300239) holds total assets worth CN¥2.57 Billion CNY (≈ $376.65 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore cash flow to debt ratio of Baotou Dongbao Bio-Tech Co Ltd to assess how comfortably operating cash covers total debt obligations.

Baotou Dongbao Bio-Tech Co Ltd - Total Assets Trend (2008–2025)

This chart illustrates how Baotou Dongbao Bio-Tech Co Ltd's total assets have evolved over time, based on quarterly financial data. See Baotou Dongbao Bio-Tech Co Ltd book value and equity for net asset value and shareholders' equity analysis.

Baotou Dongbao Bio-Tech Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2025)

Baotou Dongbao Bio-Tech Co Ltd's total assets of CN¥2.57 Billion consist of 45.0% current assets and 55.0% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	18.9%
Accounts Receivable	CN¥180.62 Million	7.1%
Inventory	CN¥401.37 Million	15.7%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥135.79 Million	5.3%
Goodwill	CN¥0.00	0.0%

Asset Composition Trend (2008–2025)

This chart illustrates how Baotou Dongbao Bio-Tech Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 300239 market cap overview.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Baotou Dongbao Bio-Tech Co Ltd's current assets represent 45.0% of total assets in 2025, an increase from 42.0% in 2008.
Cash Position: Cash and equivalents constituted 18.9% of total assets in 2025, up from 2.5% in 2008.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, an increase from 3.0% in 2008.
Asset Diversification: The largest asset category is inventory at 15.7% of total assets.

Baotou Dongbao Bio-Tech Co Ltd Competitors by Total Assets

Key competitors of Baotou Dongbao Bio-Tech Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Takeda Pharmaceutical Company Limited F:TKDA	Germany	€15.41 Trillion
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	China	CN¥19.57 Billion
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	China	CN¥2.30 Billion
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	China	CN¥8.59 Billion
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	China	CN¥925.41 Million
Jw Pharmac KO:001060	Korea	₩605.27 Billion
Kamada TA:KMDA	Israel	ILA377.21 Million
Samjin Pharm KO:005500	Korea	₩449.14 Billion

Baotou Dongbao Bio-Tech Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	4.81	4.49	3.18
Quick Ratio	3.05	3.11	2.06
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥898.40 Million	CN¥940.82 Million	CN¥519.08 Million

Baotou Dongbao Bio-Tech Co Ltd - Advanced Valuation Insights

This section examines the relationship between Baotou Dongbao Bio-Tech Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.90
Latest Market Cap to Assets Ratio	0.16
Asset Growth Rate (YoY)	-2.9%
Total Assets	CN¥2.55 Billion
Market Capitalization	$420.43 Million USD

Valuation Analysis

Below Book Valuation: The market values Baotou Dongbao Bio-Tech Co Ltd's assets below their book value (0.16x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Baotou Dongbao Bio-Tech Co Ltd's assets decreased by 2.9% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Baotou Dongbao Bio-Tech Co Ltd (2008–2025)

The table below shows the annual total assets of Baotou Dongbao Bio-Tech Co Ltd from 2008 to 2025.

Year	Total Assets	Change
2025-12-31	CN¥2.55 Billion ≈ $373.10 Million	-2.87%
2024-12-31	CN¥2.62 Billion ≈ $384.11 Million	-4.27%
2023-12-31	CN¥2.74 Billion ≈ $401.24 Million	+18.80%
2022-12-31	CN¥2.31 Billion ≈ $337.75 Million	+9.27%
2021-12-31	CN¥2.11 Billion ≈ $309.09 Million	+48.97%
2020-12-31	CN¥1.42 Billion ≈ $207.49 Million	+7.88%
2019-12-31	CN¥1.31 Billion ≈ $192.33 Million	+9.64%
2018-12-31	CN¥1.20 Billion ≈ $175.41 Million	+23.39%
2017-12-31	CN¥971.54 Million ≈ $142.17 Million	+16.61%
2016-12-31	CN¥833.13 Million ≈ $121.91 Million	+6.81%
2015-12-31	CN¥780.04 Million ≈ $114.14 Million	+47.02%
2014-12-31	CN¥530.57 Million ≈ $77.64 Million	+2.11%
2013-12-31	CN¥519.63 Million ≈ $76.04 Million	+7.08%
2012-12-31	CN¥485.26 Million ≈ $71.01 Million	+28.50%
2011-12-31	CN¥377.62 Million ≈ $55.26 Million	+71.60%
2010-12-31	CN¥220.06 Million ≈ $32.20 Million	+6.18%
2009-12-31	CN¥207.25 Million ≈ $30.33 Million	+3.57%
2008-12-31	CN¥200.11 Million ≈ $29.28 Million	--

About Baotou Dongbao Bio-Tech Co Ltd

SHE:300239 China Drug Manufacturers - Specialty & Generic

Market Cap

$420.43 Million

CN¥2.87 Billion CNY

Market Cap Rank

#13012 Global

#3805 in China

Share Price

CN¥4.84

Change (1 day)

+1.47%

52-Week Range

CN¥4.52 - CN¥6.63

All Time High

CN¥9.53